Company Filing History:
Years Active: 2012-2023
Title: The Innovative Contributions of Qi Mi
Introduction
Qi Mi is a prominent inventor based in Pittsburgh, PA (US), known for her significant contributions to the field of trauma care and inflammation modulation. With a total of 6 patents to her name, she has developed groundbreaking technologies that aim to improve patient outcomes in critical medical situations.
Latest Patents
One of her latest patents is titled "Time window-based platform for the rapid stratification of blunt trauma patients into distinct outcome cohorts." This invention provides methods for segregating trauma patients, particularly those with blunt injuries, into different cohorts based on their risk of developing multiple organ dysfunction syndrome. The methods utilize patient data collected shortly after injury, which is crucial for timely treatment and effective patient management.
Another notable patent is the "Self-regulating device for modulating inflammation." This bioreactor is designed to contain cells that produce cytokine inhibitors in response to cytokines. The production is regulated by the local or systemic environment of the patient, as predicted by mechanistic computational simulations. This innovative device aims to transfer cytokine inhibitors to patients suffering from conditions such as sepsis, trauma, traumatic brain injury, or wound healing, thereby controlling the inflammation process.
Career Highlights
Qi Mi is affiliated with the University of Pittsburgh, where she continues to advance her research and innovations in medical technology. Her work has garnered attention for its potential to transform trauma care and improve patient outcomes.
Collaborations
Throughout her career, Qi Mi has collaborated with esteemed colleagues, including Yoram Vodovotz and Gregory M. Constantine. These partnerships have further enhanced her research and contributed to the development of her innovative patents.
Conclusion
In summary, Qi Mi's contributions to the fields of trauma care and inflammation modulation are noteworthy. Her innovative patents reflect her commitment to improving patient outcomes and advancing medical technology.